Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma

NCT01139359 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Study enrollment was withdrawn as it is no longer the sponsor's intention to study this indication under this protocol.

Conditions

Interventions

Sponsor

Alaunos Therapeutics